🔎 Trials Near Me

Akèy › Maladi Entestinal Anflamatwa › Illinois

Etid klinik pou Maladi Entestinal Anflamatwa nan Illinois

7 etid pou Maladi Entestinal Anflamatwa ap chèche patisipan nan sit nan Illinois.

Vil nan Illinois

Tèks ofisyèl etid la (Anglè)

A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis

  • Northwestern University, Chicago
  • Avicenna Clinical Research - SW Gastroenterology, Oak Lawn
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Sep 30, 2026 · NCT06598943

A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis

  • Site 038, Chicago
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Sep 29, 2026 · NCT07012395

A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis

  • Site US-005, Des Plaines
  • Site US-007, Glenview
  • Site US-020, Gurnee
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Sep 29, 2026 · NCT07845487

A Study to Measure Mirikizumab Levels in Breast Milk of Lactating Participants Receiving Mirikizumab Therapeutically for an Approved Indication

  • Northwest Gastroenterologist, Glenview
Ap rekriteFaz 4
3 Weeks · Fanm · Mizajou Sep 8, 2026 · NCT07612267

A Randomized Crossover Trial of Bright Light Therapy in Crohn's Disease on Intestinal Barrier Homeostasis

  • Rush University Medical Center, Chicago
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jun 9, 2026 · NCT05579392

A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

  • Mirador Therapeutics Selected Site, Glenview
  • Mirador Therapeutics Selected Site, Gurnee
Ap rekriteFaz 2
Laj 18 a 80 · Tout sèks · Mizajou Mar 12, 2026 · NCT07113522

The 1200 Patients Project: Studying the Implementation of Clinical Pharmacogenomic Testing

  • University of Chicago Medical Center, Chicago
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Mar 4, 2026 · NCT01280825

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.